Controlled radical initiators, reaction mixtures containing the controlled radical initiators and various ethylenically unsaturated monomers, polymeric materials formed from the reaction mixtures, crosslinkable compositions containing the polymeric materials, crosslinked compositions formed from the crosslinkable compositions, and articles containing the polymeric materials, the crosslinkable compositions, or the crosslinked compositions are provided. The controlled radical initiators are bis-dithiocarbamate or bis-dithiocarbonate compounds having a single carbon between the two dithiocarbamate or dithiocarbonate groups. Also attached to that single carbon is a ketone group.

Controlled radical initiators, reaction mixtures containing the controlled radical initiators and various ethylenically unsaturated monomers, polymeric materials formed from the reaction mixtures, crosslinkable compositions containing the polymeric materials, crosslinked compositions formed from the crosslinkable compositions, and articles containing the polymeric materials, the crosslinkable compositions, or the crosslinked compositions are provided. The controlled radical initiators are bis-dithiocarbamate or bis-dithiocarbonate compounds having a single carbon between the two dithiocarbamate or dithiocarbonate groups. Also attached to that single carbon is a ketone group.

Provided are a polymer medicament for treating hyperkalemia, and a preparation method thereof. Specifically, a polymer is provided, and the polymer includes repeating units obtained by polymerizing a monomer and a crosslinking agent. A molar ratio of the monomer to the crosslinking reagent ranges from 1:0.02 to 1:0.20. The monomer includes an acidic group and a pKa-reducing group next to the acidic group. The acidic group is selected from the group consisting of sulfonic acid group (—SO.sub.3—), sulfuric acid group (—OSO.sub.3—), carboxylic group (—CO.sub.2—), phosphonic acid group (—OPO.sub.3.sup.2—), phosphate group (—OPO.sub.3.sup.2—), and sulfamic acid group (—NHSO.sub.3—). The pKa-reducing group is selected from the group consisting of nitro, cyano, carbonyl, trifluoromethyl, and halogen atoms. The crosslinking agent has three or four reaction sites. The polymer can be used to treat hyperkalemia.

Provided are a polymer medicament for treating hyperkalemia, and a preparation method thereof. Specifically, a polymer is provided, and the polymer includes repeating units obtained by polymerizing a monomer and a crosslinking agent. A molar ratio of the monomer to the crosslinking reagent ranges from 1:0.02 to 1:0.20. The monomer includes an acidic group and a pKa-reducing group next to the acidic group. The acidic group is selected from the group consisting of sulfonic acid group (—SO.sub.3—), sulfuric acid group (—OSO.sub.3—), carboxylic group (—CO.sub.2—), phosphonic acid group (—OPO.sub.3.sup.2—), phosphate group (—OPO.sub.3.sup.2—), and sulfamic acid group (—NHSO.sub.3—). The pKa-reducing group is selected from the group consisting of nitro, cyano, carbonyl, trifluoromethyl, and halogen atoms. The crosslinking agent has three or four reaction sites. The polymer can be used to treat hyperkalemia.

The purpose of the present invention is to obtain an ethylene⋅α-olefin⋅non-conjugated polyene copolymer that has a low permanent compression set at low temperatures, is flexible, and has an excellent balance of rubber elasticity at low temperatures and tensile strength at normal temperatures. This ethylene-based polymer is an ethylene⋅α-olefin⋅non-conjugated polyene copolymer that includes units derived from ethylene (A), units derived from an α-olefin (B) containing 4-20 carbon atoms, and units derived from a non-conjugated polyene (C) and satisfies (1)-(4). (1) The molar ratio of (A) to (B) is 40/60-90/10, (2) the contained amount of the units derived from (C) is 0.1-6.0 mol %, (3) ML.sub.(1+4)125° C. is 5-100, and (4) the B value is 1.20 or more.

The purpose of the present invention is to obtain an ethylene⋅α-olefin⋅non-conjugated polyene copolymer that has a low permanent compression set at low temperatures, is flexible, and has an excellent balance of rubber elasticity at low temperatures and tensile strength at normal temperatures. This ethylene-based polymer is an ethylene⋅α-olefin⋅non-conjugated polyene copolymer that includes units derived from ethylene (A), units derived from an α-olefin (B) containing 4-20 carbon atoms, and units derived from a non-conjugated polyene (C) and satisfies (1)-(4). (1) The molar ratio of (A) to (B) is 40/60-90/10, (2) the contained amount of the units derived from (C) is 0.1-6.0 mol %, (3) ML.sub.(1+4)125° C. is 5-100, and (4) the B value is 1.20 or more.

The present invention provides a crosslinked molded article having a lower compression set; and a method for producing a crosslinked molded article by injection molding, the method enabling shortening of one cycle in injection molding, the method being suitable for obtaining a crosslinked molded article having a lower compression set. The present invention relates to a method for producing a crosslinked molded article, comprising melt-kneading a polymer composition containing a polymer having a terminal double bond, a hydrosilyl group-containing compound (Y) having at least two hydrosilyl groups per molecule, a platinum-based catalyst (Z) for hydrosilicon crosslinking, and a reaction inhibitor (D), subjecting the polymer composition to injection molding in a mold, performing primary crosslinking in the mold, removing the primary-crosslinked molded article from the mold, and then performing secondary crosslinking in a heat medium.

The invention relates to an unsaturated polyester resin composition comprising: —a (meth)acrylate compound; and, —a polyester formed from at least: —reagent a) comprising itaconic acid and/or itaconic anhydride; —reagent b) comprising maleic acid, maleic anhydride, and/or fumaric acid; —reagent c) comprising dicyclopentadiene (DCPD); and, —reagent d) comprising at least one di- or poly-functional alcohol, preferably at least one diol; wherein the combined weight of reagent a) (i.e. the combined weight of itaconic acid and/or itaconic anhydride) is at least 10 wt. %, preferably at least 20 wt. %, of the total weight of di-acids and anhydrides used in the unsaturated polyester resin composition. The invention further relates to use of said unsaturated polyester resin for structural parts and for gel-coats. The invention also provides methods for preparing said unsaturated polyester resin composition.

The invention relates to an unsaturated polyester resin composition comprising: —a (meth)acrylate compound; and, —a polyester formed from at least: —reagent a) comprising itaconic acid and/or itaconic anhydride; —reagent b) comprising maleic acid, maleic anhydride, and/or fumaric acid; —reagent c) comprising dicyclopentadiene (DCPD); and, —reagent d) comprising at least one di- or poly-functional alcohol, preferably at least one diol; wherein the combined weight of reagent a) (i.e. the combined weight of itaconic acid and/or itaconic anhydride) is at least 10 wt. %, preferably at least 20 wt. %, of the total weight of di-acids and anhydrides used in the unsaturated polyester resin composition. The invention further relates to use of said unsaturated polyester resin for structural parts and for gel-coats. The invention also provides methods for preparing said unsaturated polyester resin composition.

The present disclosure provides a composition. The composition is crosslinkable and includes an ethylene silane-copolymer, an oil-extended ethylene-propylene-diene monomer (EPDM), and a crosslink catalyst. The present disclosure also provides the composition after crosslinking. In an embodiment, a crosslinked composition is provided and includes from 55 wt % to 85 wt % of an ethylene-silane copolymer and from 15 wt % to 45 wt % of an oil-extended EPDM. The crosslinked composition has: (a) a flexural modulus of 50 MPa to 160 MPa; and (b) a hot set elongation greater than 10%. The crosslinked composition can be used as a coating for a coated conductor.